7986 related articles for article (PubMed ID: 10230579)
1. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
Lindelöf B
Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
Stern RS; Nichols KT; Väkevä LH
N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
[TBL] [Abstract][Full Text] [Related]
4. Comparative tolerability of systemic treatments for plaque-type psoriasis.
McClure SL; Valentine J; Gordon KB
Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
[TBL] [Abstract][Full Text] [Related]
5. PUVA and cancer risk: the Swedish follow-up study.
Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L
Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
[TBL] [Abstract][Full Text] [Related]
6. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
7. Consensus workshop on the toxic effects of long-term PUVA therapy.
Morison WL; Baughman RD; Day RM; Forbes PD; Hoenigsmann H; Krueger GG; Lebwohl M; Lew R; Naldi L; Parrish JA; Piepkorn M; Stern RS; Weinstein GD; Whitmore SE
Arch Dermatol; 1998 May; 134(5):595-8. PubMed ID: 9606329
[TBL] [Abstract][Full Text] [Related]
8. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
Gasparro FP
Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
[TBL] [Abstract][Full Text] [Related]
9. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
Stern RS; Liebman EJ; Väkevä L
J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
[TBL] [Abstract][Full Text] [Related]
10. PUVA improvements will come from molecular biology.
Gasparro FP
Photodermatol Photoimmunol Photomed; 2000 Apr; 16(2):83-4. PubMed ID: 10823319
[No Abstract] [Full Text] [Related]
11. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
Stern RS;
J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
[TBL] [Abstract][Full Text] [Related]
12. Treatments for psoriasis and the risk of malignancy.
Patel RV; Clark LN; Lebwohl M; Weinberg JM
J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.
Dayal S; ; Jain VK
Indian J Dermatol Venereol Leprol; 2010; 76(5):533-7. PubMed ID: 20826993
[TBL] [Abstract][Full Text] [Related]
14. Minimising the risks of PUVA treatment.
van Praag MC; Tseng LN; Mommaas AM; Boom BW; Vermeer BJ
Drug Saf; 1993 May; 8(5):340-9. PubMed ID: 8504016
[TBL] [Abstract][Full Text] [Related]
15. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P
J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous melanomas in patients treated with psoralens plus ultraviolet A. A case report and the experience of the PUVA Follow-up Study.
Gupta AK; Stern RS; Swanson NA; Anderson TF
J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):67-76. PubMed ID: 3403747
[TBL] [Abstract][Full Text] [Related]
17. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
Stern RS
Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
[TBL] [Abstract][Full Text] [Related]
18. Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
Naldi L; Griffiths CE
Br J Dermatol; 2005 Apr; 152(4):597-615. PubMed ID: 15840088
[TBL] [Abstract][Full Text] [Related]
19. Psoralens and related compounds in the treatment of psoriasis.
McEvoy MT; Stern RS
Pharmacol Ther; 1987; 34(1):75-97. PubMed ID: 3310045
[TBL] [Abstract][Full Text] [Related]
20. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
Stern RS; Laird N
Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
